RCKT
#3035
Rocket Pharmaceuticals, Inc. - Common Stock
3.8 6 USD
+0.07%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+6.63%
Monthly Change
+22.93%
6 month change
-21.70%
Year Change
+18.04%
Previous Close
3.6 2
Open
3.8 6
Low
3.8 6
High
3.8 6
Volume
71
Financials
- Market Capitalization 423.73 M
- Employee 202
- Founded 1999
- CEO N/A
- Website www.rocketpharma.com
- Headquarter Delaware, United States
- FIGI BBG000WG3567
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3026 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.36 USD | -1.65% | -0.56% | +16.52% | +66.98% | 429.90 M USD | ||
| 3029 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.47 USD | -1.58% | -7.83% | +2.89% | -24.92% | 428.40 M USD | ||
| 3050 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 4.01 USD | -0.99% | -5.20% | +9.86% | +9.56% | 416.57 M USD | ||
| 3069 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.02 USD | -2.90% | +9.24% | +14.53% | -6.07% | 405.42 M USD |
Frequently asked questions about Rocket Pharmaceuticals, Inc. Common Stock
What is the Rocket Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is 3.86. Over the past 24 hours, the stock has changed by +6.63%. Follow the RCKT chart for real-time price dynamics.
What is the stock ticker of Rocket Pharmaceuticals, Inc. Common Stock?
Rocket Pharmaceuticals, Inc. Common Stock trades under the ticker RCKT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rocket Pharmaceuticals, Inc. Common Stock stock going up?
RCKT has changed by +9.35% over the last week, +22.93% over the last month, and +18.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rocket Pharmaceuticals, Inc. Common Stock?
Rocket Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 423.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rocket Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Rocket Pharmaceuticals, Inc. Common Stock reported earnings of 1.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rocket Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Rocket Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rocket Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Rocket Pharmaceuticals, Inc. Common Stock reported net income of 123.21 M for the last quarter. The previous quarter showed -47.59 M, which means net income changed by +358.89%.
How many employees does Rocket Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Rocket Pharmaceuticals, Inc. Common Stock has 202 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Rocket Pharmaceuticals, Inc. Common Stock stock?
You can buy Rocket Pharmaceuticals, Inc. Common Stock (RCKT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rocket Pharmaceuticals, Inc. Common Stock stock?
Investing in Rocket Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RCKT chart and related analysis on metatrader.com as part of your research.